[
  {
    "ts": null,
    "headline": "Wedgewood Partners: Q4 2025 Top Performers And Detractors",
    "summary": "Alphabet continued to make significant contributions to performance during the quarter. Taiwan Semiconductor Manufacturing also contributed to performance during the quarter.",
    "url": "https://finnhub.io/api/news?id=30e956365d74ebee01258d3d9f5cc758536ea875db95283e46a4adfdabf133db",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768457400,
      "headline": "Wedgewood Partners: Q4 2025 Top Performers And Detractors",
      "id": 138119578,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2213627041/image_2213627041.jpg?io=getty-c-w1536",
      "related": "EW",
      "source": "SeekingAlpha",
      "summary": "Alphabet continued to make significant contributions to performance during the quarter. Taiwan Semiconductor Manufacturing also contributed to performance during the quarter.",
      "url": "https://finnhub.io/api/news?id=30e956365d74ebee01258d3d9f5cc758536ea875db95283e46a4adfdabf133db"
    }
  },
  {
    "ts": null,
    "headline": "Edwards Lifesciences (EW) Valuation Check As Recent Share Momentum Meets Premium P/E Pricing",
    "summary": "With no single headline event in focus, Edwards Lifesciences (EW) is drawing attention for its recent share performance and financial profile, prompting investors to reassess how its current valuation lines up with fundamentals. See our latest analysis for Edwards Lifesciences. At a share price of $83.10, Edwards Lifesciences has seen short term pressure, including a 1-day share price return decline of 0.88%. By contrast, a 90-day share price return of 14.38% and a 1-year total shareholder...",
    "url": "https://finnhub.io/api/news?id=5875d20aeb2a8c4433928eb0dab612c5d6fd97cca7cf5cec6c059bdc91492370",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768439262,
      "headline": "Edwards Lifesciences (EW) Valuation Check As Recent Share Momentum Meets Premium P/E Pricing",
      "id": 138116756,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "With no single headline event in focus, Edwards Lifesciences (EW) is drawing attention for its recent share performance and financial profile, prompting investors to reassess how its current valuation lines up with fundamentals. See our latest analysis for Edwards Lifesciences. At a share price of $83.10, Edwards Lifesciences has seen short term pressure, including a 1-day share price return decline of 0.88%. By contrast, a 90-day share price return of 14.38% and a 1-year total shareholder...",
      "url": "https://finnhub.io/api/news?id=5875d20aeb2a8c4433928eb0dab612c5d6fd97cca7cf5cec6c059bdc91492370"
    }
  }
]